{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:41:33Z","timestamp":1790649693426,"version":"4.1.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,11,20]]},"DOI":"10.4103\/0366-6999.169068","type":"journal-article","created":{"date-parts":[[2015,11,9]],"date-time":"2015-11-09T05:19:42Z","timestamp":1447046382000},"page":"3050-3054","source":"Crossref","is-referenced-by-count":21,"title":["Thalidomide Effects in Patients with Hereditary Hemorrhagic Telangiectasia During Therapeutic Treatment and in Fli-EGFP Transgenic Zebrafish Model"],"prefix":"10.1097","volume":"128","author":[{"given":"Hong-Ling","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Fang","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun-Ke","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Si","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Sen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20210129","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/lary.20818","article-title":"An Epistaxis Severity Score for hereditary hemorrhagic telangiectasia","volume":"120","author":"Hoag","year":"2010","journal-title":"Laryngoscope"},{"key":"R2-11-20210129","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/lary.21415","article-title":"Efficacy of intranasal bevacizumab (Avastin) treatment in patients with hereditary hemorrhagic telangiectasia-associated epistaxis","volume":"121","author":"Karnezis","year":"2011","journal-title":"Laryngoscope"},{"key":"R3-11-20210129","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/lary.22501","article-title":"Treatment of hereditary hemorrhagic telangiectasia with submucosal and topical bevacizumab therapy","volume":"122","author":"Karnezis","year":"2012","journal-title":"Laryngoscope"},{"key":"R4-11-20210129","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/lary.23230","article-title":"Bevacizumab nasal spray: Noninvasive treatment of epistaxis in patients with Rendu-Osler disease","volume":"122","author":"Guldmann","year":"2012","journal-title":"Laryngoscope"},{"key":"R5-11-20210129","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1177\/0091270011417824","article-title":"Long-term therapy with thalidomide in hereditary hemorrhagic telangiectasia: Case report and literature review","volume":"52","author":"Chen","year":"2012","journal-title":"J Clin Pharmacol"},{"key":"R6-11-20210129","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1159\/000323152","article-title":"A case report of a patient with hereditary hemorrhagic telangiectasia treated successively with thalidomide and bevacizumab","volume":"3","author":"Amanzada","year":"2010","journal-title":"Case Rep Oncol"},{"key":"R7-11-20210129","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nm.2131","article-title":"Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia","volume":"16","author":"Lebrin","year":"2010","journal-title":"Nat Med"},{"key":"R8-11-20210129","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P","article-title":"Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome)","volume":"91","author":"Shovlin","year":"2000","journal-title":"Am J Med Genet"},{"key":"R9-11-20210129","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/S0140-6736(04)16308-3","article-title":"Thalidomide","volume":"363","author":"Franks","year":"2004","journal-title":"Lancet"},{"key":"R10-11-20210129","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.tcb.2010.06.006","article-title":"Signaling by members of the TGF-beta family in vascular morphogenesis and disease","volume":"20","author":"Pardali","year":"2010","journal-title":"Trends Cell Biol"},{"key":"R11-11-20210129","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"R12-11-20210129","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1242\/dev.123.1.303","article-title":"Hematopoietic mutations in the zebrafish","volume":"123","author":"Weinstein","year":"1996","journal-title":"Development"},{"key":"R13-11-20210129","doi-asserted-by":"crossref","first-page":"e58031","DOI":"10.1371\/journal.pone.0058031","article-title":"An intron mutation in the ACVRL1 may be associated with a transcriptional regulation defect in a Chinese family with hereditary hemorrhagic telangiectasia","volume":"8","author":"Yu","year":"2013","journal-title":"PLoS One"},{"key":"R14-11-20210129","first-page":"1114","article-title":"Successful treatment of thalidomide for recurrent bleeding due to gastric angiodysplasia in hereditary hemorrhagic telangiectasia","volume":"17","author":"Wang","year":"2013","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R15-11-20210129","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/MBC.0b013e32834a040c","article-title":"Deep vein thrombosis induced by thalidomide to control epistaxis secondary to hereditary haemorrhagic telangiectasia","volume":"22","author":"Penaloza","year":"2011","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R17-11-20210129","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.2741\/3573","article-title":"Transforming growth factor-beta signaling and tumor angiogenesis","volume":"14","author":"Pardali","year":"2009","journal-title":"Front Biosci (Landmark Ed"},{"key":"R18-11-20210129","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1093\/emboj\/21.7.1743","article-title":"Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors","volume":"21","author":"Goumans","year":"2002","journal-title":"EMBO J"},{"key":"R19-11-20210129","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1359-6101(96)00048-2","article-title":"Transforming growth factor-beta: Vasculogenesis, angiogenesis, and vessel wall integrity","volume":"8","author":"Pepper","year":"1997","journal-title":"Cytokine Growth Factor Rev"},{"key":"R20-11-20210129","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.bcp.2008.10.036","article-title":"TGFbeta1 antagonistic peptides inhibit TGFbeta1-dependent angiogenesis","volume":"77","author":"Serrat\u00ec","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"R21-11-20210129","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1084\/jem.20091309","article-title":"Genetic and pharmacological targeting of activin receptor-like kinase 1 impairs tumor growth and angiogenesis","volume":"207","author":"Cunha","year":"2010","journal-title":"J Exp Med"},{"key":"R22-11-20210129","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1200\/JCO.2005.06.081","article-title":"Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis","volume":"23","author":"Hicklin","year":"2005","journal-title":"J Clin Oncol"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/0366-6999.169068","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T17:19:05Z","timestamp":1653499145000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00029330-201511200-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,20]]},"references-count":21,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.4103\/0366-6999.169068","relation":{},"ISSN":["0366-6999"],"issn-type":[{"value":"0366-6999","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11,20]]}}}